NO329660B1 - cDNA, RNA, vektor, vertcelle, kimaert ikke-patogent akvatisk birnavirus, levende ikke-patogene IPNV, vaksine samt fremgangsmate for fremstilling - Google Patents
cDNA, RNA, vektor, vertcelle, kimaert ikke-patogent akvatisk birnavirus, levende ikke-patogene IPNV, vaksine samt fremgangsmate for fremstilling Download PDFInfo
- Publication number
- NO329660B1 NO329660B1 NO20004914A NO20004914A NO329660B1 NO 329660 B1 NO329660 B1 NO 329660B1 NO 20004914 A NO20004914 A NO 20004914A NO 20004914 A NO20004914 A NO 20004914A NO 329660 B1 NO329660 B1 NO 329660B1
- Authority
- NO
- Norway
- Prior art keywords
- virus
- cdna
- ipnv
- segment
- pathogenic
- Prior art date
Links
- 241000710921 Infectious pancreatic necrosis virus Species 0.000 title claims description 167
- 241000700605 Viruses Species 0.000 title claims description 154
- 239000002299 complementary DNA Substances 0.000 title claims description 88
- 238000000034 method Methods 0.000 title claims description 34
- 229960005486 vaccine Drugs 0.000 title claims description 34
- 230000001717 pathogenic effect Effects 0.000 title claims description 30
- 239000013598 vector Substances 0.000 title claims description 27
- 238000002360 preparation method Methods 0.000 title description 6
- 108091032973 (ribonucleotides)n+m Proteins 0.000 claims description 77
- 108090000623 proteins and genes Proteins 0.000 claims description 75
- 102000004169 proteins and genes Human genes 0.000 claims description 68
- 230000014509 gene expression Effects 0.000 claims description 31
- 238000004519 manufacturing process Methods 0.000 claims description 27
- 238000013518 transcription Methods 0.000 claims description 18
- 230000035897 transcription Effects 0.000 claims description 18
- 241000972773 Aulopiformes Species 0.000 claims description 17
- 238000001890 transfection Methods 0.000 claims description 17
- 235000019515 salmon Nutrition 0.000 claims description 16
- 239000000427 antigen Substances 0.000 claims description 15
- 108091007433 antigens Proteins 0.000 claims description 15
- 102000036639 antigens Human genes 0.000 claims description 15
- 230000003612 virological effect Effects 0.000 claims description 13
- 101150076514 NS gene Proteins 0.000 claims description 12
- 239000001963 growth medium Substances 0.000 claims description 12
- 230000002950 deficient Effects 0.000 claims description 8
- 230000001580 bacterial effect Effects 0.000 claims description 7
- 239000003937 drug carrier Substances 0.000 claims description 6
- 108091081024 Start codon Proteins 0.000 claims description 5
- 238000002955 isolation Methods 0.000 claims description 5
- 210000001161 mammalian embryo Anatomy 0.000 claims description 5
- 241000711804 Infectious hematopoietic necrosis virus Species 0.000 claims description 4
- 241000546112 Infectious salmon anemia virus Species 0.000 claims description 4
- 241001125819 Ameiurus nebulosus Species 0.000 claims description 3
- 241000894006 Bacteria Species 0.000 claims description 3
- 238000012986 modification Methods 0.000 claims description 3
- 230000004048 modification Effects 0.000 claims description 3
- 241000122170 Aliivibrio salmonicida Species 0.000 claims description 2
- 108020004705 Codon Proteins 0.000 claims description 2
- 241000604777 Flavobacterium columnare Species 0.000 claims description 2
- 241000382842 Flavobacterium psychrophilum Species 0.000 claims description 2
- 241000701372 Iridovirus Species 0.000 claims description 2
- 241000194040 Lactococcus garvieae Species 0.000 claims description 2
- 241000721654 Lepomis macrochirus Species 0.000 claims description 2
- 208000016222 Pancreatic disease Diseases 0.000 claims description 2
- 241000295697 Pimephales promelas Species 0.000 claims description 2
- 241000192126 Piscirickettsia salmonis Species 0.000 claims description 2
- 241000186812 Renibacterium salmoninarum Species 0.000 claims description 2
- 241000607734 Yersinia <bacteria> Species 0.000 claims description 2
- 241000607534 Aeromonas Species 0.000 claims 1
- 208000032969 Hemorrhagic Septicemia Diseases 0.000 claims 1
- 241001600139 Moritella viscosa Species 0.000 claims 1
- 241001327682 Oncorhynchus mykiss irideus Species 0.000 claims 1
- 208000014645 Pasteurella hemorrhagic septicemia Diseases 0.000 claims 1
- 241000544286 Vibrio anguillarum Species 0.000 claims 1
- 210000002149 gonad Anatomy 0.000 claims 1
- 238000011534 incubation Methods 0.000 claims 1
- 210000004027 cell Anatomy 0.000 description 85
- 239000013612 plasmid Substances 0.000 description 68
- 235000018102 proteins Nutrition 0.000 description 57
- 235000019688 fish Nutrition 0.000 description 47
- 208000015181 infectious disease Diseases 0.000 description 45
- 241000251468 Actinopterygii Species 0.000 description 41
- 239000012634 fragment Substances 0.000 description 37
- 230000002458 infectious effect Effects 0.000 description 29
- 238000010240 RT-PCR analysis Methods 0.000 description 22
- 239000002773 nucleotide Substances 0.000 description 20
- 125000003729 nucleotide group Chemical group 0.000 description 20
- 108020004414 DNA Proteins 0.000 description 19
- 102000040650 (ribonucleotides)n+m Human genes 0.000 description 18
- 101710137500 T7 RNA polymerase Proteins 0.000 description 17
- 239000000047 product Substances 0.000 description 17
- 238000000338 in vitro Methods 0.000 description 16
- 241000702626 Infectious bursal disease virus Species 0.000 description 15
- 238000010276 construction Methods 0.000 description 13
- 230000002441 reversible effect Effects 0.000 description 13
- 101710118046 RNA-directed RNA polymerase Proteins 0.000 description 12
- 241000277331 Salmonidae Species 0.000 description 12
- 101710132601 Capsid protein Proteins 0.000 description 11
- 101710197658 Capsid protein VP1 Proteins 0.000 description 11
- 108700026244 Open Reading Frames Proteins 0.000 description 11
- 101710108545 Viral protein 1 Proteins 0.000 description 11
- 241001493065 dsRNA viruses Species 0.000 description 11
- 230000010076 replication Effects 0.000 description 11
- 238000012300 Sequence Analysis Methods 0.000 description 10
- 108010087302 Viral Structural Proteins Proteins 0.000 description 10
- 230000003321 amplification Effects 0.000 description 10
- 230000035772 mutation Effects 0.000 description 10
- 238000003199 nucleic acid amplification method Methods 0.000 description 10
- 108091008146 restriction endonucleases Proteins 0.000 description 10
- 108060004795 Methyltransferase Proteins 0.000 description 9
- 101710172711 Structural protein Proteins 0.000 description 9
- 230000002068 genetic effect Effects 0.000 description 9
- 102000004190 Enzymes Human genes 0.000 description 8
- 108090000790 Enzymes Proteins 0.000 description 8
- 241000277263 Salmo Species 0.000 description 8
- 238000003556 assay Methods 0.000 description 8
- 230000015572 biosynthetic process Effects 0.000 description 8
- 229940088598 enzyme Drugs 0.000 description 8
- 102000039446 nucleic acids Human genes 0.000 description 8
- 108020004707 nucleic acids Proteins 0.000 description 8
- 150000007523 nucleic acids Chemical class 0.000 description 8
- 210000000496 pancreas Anatomy 0.000 description 8
- 238000002741 site-directed mutagenesis Methods 0.000 description 8
- 239000006228 supernatant Substances 0.000 description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 8
- 238000004458 analytical method Methods 0.000 description 7
- 239000002585 base Substances 0.000 description 7
- 239000000969 carrier Substances 0.000 description 7
- 201000010099 disease Diseases 0.000 description 7
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 7
- 210000003020 exocrine pancreas Anatomy 0.000 description 7
- 238000001727 in vivo Methods 0.000 description 7
- 230000029812 viral genome replication Effects 0.000 description 7
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 6
- 108010076039 Polyproteins Proteins 0.000 description 6
- 239000000872 buffer Substances 0.000 description 6
- 238000006243 chemical reaction Methods 0.000 description 6
- 238000007654 immersion Methods 0.000 description 6
- 238000010166 immunofluorescence Methods 0.000 description 6
- 239000010978 jasper Substances 0.000 description 6
- 108010074906 nuclear scaffold serine protease Proteins 0.000 description 6
- 210000004923 pancreatic tissue Anatomy 0.000 description 6
- 238000011084 recovery Methods 0.000 description 6
- 210000002966 serum Anatomy 0.000 description 6
- 230000014616 translation Effects 0.000 description 6
- 241000237852 Mollusca Species 0.000 description 5
- 108091092724 Noncoding DNA Proteins 0.000 description 5
- 241000283973 Oryctolagus cuniculus Species 0.000 description 5
- 241000702263 Reovirus sp. Species 0.000 description 5
- 241000702670 Rotavirus Species 0.000 description 5
- 230000000120 cytopathologic effect Effects 0.000 description 5
- 210000002907 exocrine cell Anatomy 0.000 description 5
- 230000028993 immune response Effects 0.000 description 5
- 238000010839 reverse transcription Methods 0.000 description 5
- 235000015170 shellfish Nutrition 0.000 description 5
- 238000003786 synthesis reaction Methods 0.000 description 5
- 238000013519 translation Methods 0.000 description 5
- 241000991587 Enterovirus C Species 0.000 description 4
- 206010061218 Inflammation Diseases 0.000 description 4
- 241001465754 Metazoa Species 0.000 description 4
- 108091028043 Nucleic acid sequence Proteins 0.000 description 4
- 239000002671 adjuvant Substances 0.000 description 4
- 150000001413 amino acids Chemical class 0.000 description 4
- 230000002238 attenuated effect Effects 0.000 description 4
- 238000004113 cell culture Methods 0.000 description 4
- 230000004054 inflammatory process Effects 0.000 description 4
- 239000007924 injection Substances 0.000 description 4
- 238000002347 injection Methods 0.000 description 4
- 230000003902 lesion Effects 0.000 description 4
- 230000008506 pathogenesis Effects 0.000 description 4
- 239000002953 phosphate buffered saline Substances 0.000 description 4
- 108090000765 processed proteins & peptides Proteins 0.000 description 4
- 210000001995 reticulocyte Anatomy 0.000 description 4
- 239000003381 stabilizer Substances 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- 230000009447 viral pathogenesis Effects 0.000 description 4
- 210000002845 virion Anatomy 0.000 description 4
- 208000009663 Acute Necrotizing Pancreatitis Diseases 0.000 description 3
- 241000237502 Ostreidae Species 0.000 description 3
- 206010058096 Pancreatic necrosis Diseases 0.000 description 3
- 241000711798 Rabies lyssavirus Species 0.000 description 3
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 3
- 238000012512 characterization method Methods 0.000 description 3
- 239000007795 chemical reaction product Substances 0.000 description 3
- 239000003153 chemical reaction reagent Substances 0.000 description 3
- 238000010367 cloning Methods 0.000 description 3
- 238000005520 cutting process Methods 0.000 description 3
- 230000007850 degeneration Effects 0.000 description 3
- 238000012217 deletion Methods 0.000 description 3
- 230000037430 deletion Effects 0.000 description 3
- 238000001514 detection method Methods 0.000 description 3
- 238000011161 development Methods 0.000 description 3
- 230000018109 developmental process Effects 0.000 description 3
- 239000003085 diluting agent Substances 0.000 description 3
- 230000008030 elimination Effects 0.000 description 3
- 238000003379 elimination reaction Methods 0.000 description 3
- 239000000499 gel Substances 0.000 description 3
- 230000012010 growth Effects 0.000 description 3
- 238000003125 immunofluorescent labeling Methods 0.000 description 3
- 230000000366 juvenile effect Effects 0.000 description 3
- 239000006166 lysate Substances 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 230000007246 mechanism Effects 0.000 description 3
- 239000002609 medium Substances 0.000 description 3
- 238000010369 molecular cloning Methods 0.000 description 3
- 230000017074 necrotic cell death Effects 0.000 description 3
- 235000020636 oyster Nutrition 0.000 description 3
- 244000052769 pathogen Species 0.000 description 3
- 239000008188 pellet Substances 0.000 description 3
- 229920001184 polypeptide Polymers 0.000 description 3
- 239000002243 precursor Substances 0.000 description 3
- 102000004196 processed proteins & peptides Human genes 0.000 description 3
- 230000005855 radiation Effects 0.000 description 3
- 241000894007 species Species 0.000 description 3
- 210000001519 tissue Anatomy 0.000 description 3
- 241000712461 unidentified influenza virus Species 0.000 description 3
- 238000002255 vaccination Methods 0.000 description 3
- 229920000936 Agarose Polymers 0.000 description 2
- 241001533425 Aquabirnavirus Species 0.000 description 2
- 241000702628 Birnaviridae Species 0.000 description 2
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 2
- 208000027312 Bursal disease Diseases 0.000 description 2
- 241000725585 Chicken anemia virus Species 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- 108091026890 Coding region Proteins 0.000 description 2
- 241000252233 Cyprinus carpio Species 0.000 description 2
- 238000001712 DNA sequencing Methods 0.000 description 2
- 241000238557 Decapoda Species 0.000 description 2
- FUTAPPOITCCWTH-WHFBIAKZSA-N Gly-Asp-Asp Chemical group [H]NCC(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(O)=O)C(O)=O FUTAPPOITCCWTH-WHFBIAKZSA-N 0.000 description 2
- WZUVPPKBWHMQCE-UHFFFAOYSA-N Haematoxylin Chemical compound C12=CC(O)=C(O)C=C2CC2(O)C1C1=CC=C(O)C(O)=C1OC2 WZUVPPKBWHMQCE-UHFFFAOYSA-N 0.000 description 2
- 241001533440 Hypovirus Species 0.000 description 2
- 102100034343 Integrase Human genes 0.000 description 2
- 238000012408 PCR amplification Methods 0.000 description 2
- 229910019142 PO4 Inorganic materials 0.000 description 2
- 108091005804 Peptidases Proteins 0.000 description 2
- 241000269799 Perca fluviatilis Species 0.000 description 2
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 2
- 239000004365 Protease Substances 0.000 description 2
- 238000012181 QIAquick gel extraction kit Methods 0.000 description 2
- 230000006819 RNA synthesis Effects 0.000 description 2
- 108010092799 RNA-directed DNA polymerase Proteins 0.000 description 2
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 2
- 241000277284 Salvelinus fontinalis Species 0.000 description 2
- 229930006000 Sucrose Natural products 0.000 description 2
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 2
- 241000656145 Thyrsites atun Species 0.000 description 2
- 101150024766 VP1 gene Proteins 0.000 description 2
- 108010067390 Viral Proteins Proteins 0.000 description 2
- 108020000999 Viral RNA Proteins 0.000 description 2
- 230000010530 Virus Neutralization Effects 0.000 description 2
- HMNZFMSWFCAGGW-XPWSMXQVSA-N [3-[hydroxy(2-hydroxyethoxy)phosphoryl]oxy-2-[(e)-octadec-9-enoyl]oxypropyl] (e)-octadec-9-enoate Chemical compound CCCCCCCC\C=C\CCCCCCCC(=O)OCC(COP(O)(=O)OCCO)OC(=O)CCCCCCC\C=C\CCCCCCCC HMNZFMSWFCAGGW-XPWSMXQVSA-N 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 150000007513 acids Chemical class 0.000 description 2
- 238000000246 agarose gel electrophoresis Methods 0.000 description 2
- 230000006907 apoptotic process Effects 0.000 description 2
- 238000013459 approach Methods 0.000 description 2
- 238000009360 aquaculture Methods 0.000 description 2
- 244000144974 aquaculture Species 0.000 description 2
- 210000000234 capsid Anatomy 0.000 description 2
- 230000003833 cell viability Effects 0.000 description 2
- 238000005119 centrifugation Methods 0.000 description 2
- 239000000287 crude extract Substances 0.000 description 2
- 231100000433 cytotoxic Toxicity 0.000 description 2
- 230000001472 cytotoxic effect Effects 0.000 description 2
- 230000001066 destructive effect Effects 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 239000012091 fetal bovine serum Substances 0.000 description 2
- 208000010824 fish disease Diseases 0.000 description 2
- 239000013505 freshwater Substances 0.000 description 2
- 230000002538 fungal effect Effects 0.000 description 2
- 239000008187 granular material Substances 0.000 description 2
- 230000012447 hatching Effects 0.000 description 2
- 230000002779 inactivation Effects 0.000 description 2
- 239000003112 inhibitor Substances 0.000 description 2
- 238000011081 inoculation Methods 0.000 description 2
- 239000007928 intraperitoneal injection Substances 0.000 description 2
- 229940124590 live attenuated vaccine Drugs 0.000 description 2
- 229940023012 live-attenuated vaccine Drugs 0.000 description 2
- 238000013507 mapping Methods 0.000 description 2
- 239000003550 marker Substances 0.000 description 2
- 108020004999 messenger RNA Proteins 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 239000013642 negative control Substances 0.000 description 2
- 210000000056 organ Anatomy 0.000 description 2
- 230000001575 pathological effect Effects 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 2
- 239000010452 phosphate Substances 0.000 description 2
- 229920001223 polyethylene glycol Polymers 0.000 description 2
- 235000019419 proteases Nutrition 0.000 description 2
- 230000003362 replicative effect Effects 0.000 description 2
- 230000000405 serological effect Effects 0.000 description 2
- 239000005720 sucrose Substances 0.000 description 2
- -1 /or Species 0.000 description 1
- 101710154545 16 kDa protein Proteins 0.000 description 1
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 1
- 208000030090 Acute Disease Diseases 0.000 description 1
- 241000607525 Aeromonas salmonicida Species 0.000 description 1
- 102100027211 Albumin Human genes 0.000 description 1
- 108010088751 Albumins Proteins 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- 241000271566 Aves Species 0.000 description 1
- NOWKCMXCCJGMRR-UHFFFAOYSA-N Aziridine Chemical compound C1CN1 NOWKCMXCCJGMRR-UHFFFAOYSA-N 0.000 description 1
- 241000374455 Bhanja serogroup Species 0.000 description 1
- 241000282461 Canis lupus Species 0.000 description 1
- 241000283707 Capra Species 0.000 description 1
- 108090000565 Capsid Proteins Proteins 0.000 description 1
- 102100023321 Ceruloplasmin Human genes 0.000 description 1
- 108020004635 Complementary DNA Proteins 0.000 description 1
- 108091035707 Consensus sequence Proteins 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- 108010008286 DNA nucleotidylexotransferase Proteins 0.000 description 1
- 102100033215 DNA nucleotidylexotransferase Human genes 0.000 description 1
- 108090000626 DNA-directed RNA polymerases Proteins 0.000 description 1
- 102000004163 DNA-directed RNA polymerases Human genes 0.000 description 1
- 102000016911 Deoxyribonucleases Human genes 0.000 description 1
- 108010053770 Deoxyribonucleases Proteins 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- SNRUBQQJIBEYMU-UHFFFAOYSA-N Dodecane Natural products CCCCCCCCCCCC SNRUBQQJIBEYMU-UHFFFAOYSA-N 0.000 description 1
- 241000255581 Drosophila <fruit fly, genus> Species 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- 108010067770 Endopeptidase K Proteins 0.000 description 1
- 102000010911 Enzyme Precursors Human genes 0.000 description 1
- 108010062466 Enzyme Precursors Proteins 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 241000192125 Firmicutes Species 0.000 description 1
- 241000710198 Foot-and-mouth disease virus Species 0.000 description 1
- 241000287828 Gallus gallus Species 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 206010053759 Growth retardation Diseases 0.000 description 1
- 241000238631 Hexapoda Species 0.000 description 1
- 241000252498 Ictalurus punctatus Species 0.000 description 1
- ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 description 1
- 101800000268 Leader protease Proteins 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- 108091034117 Oligonucleotide Proteins 0.000 description 1
- 241000277275 Oncorhynchus mykiss Species 0.000 description 1
- 241001280377 Oncorhynchus tshawytscha Species 0.000 description 1
- 241000702244 Orthoreovirus Species 0.000 description 1
- 108010067035 Pancrelipase Proteins 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 1
- 108010076504 Protein Sorting Signals Proteins 0.000 description 1
- 101150075200 S-2 gene Proteins 0.000 description 1
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 210000001744 T-lymphocyte Anatomy 0.000 description 1
- 241000255588 Tephritidae Species 0.000 description 1
- 206010044565 Tremor Diseases 0.000 description 1
- GLNADSQYFUSGOU-GPTZEZBUSA-J Trypan blue Chemical compound [Na+].[Na+].[Na+].[Na+].C1=C(S([O-])(=O)=O)C=C2C=C(S([O-])(=O)=O)C(/N=N/C3=CC=C(C=C3C)C=3C=C(C(=CC=3)\N=N\C=3C(=CC4=CC(=CC(N)=C4C=3O)S([O-])(=O)=O)S([O-])(=O)=O)C)=C(O)C2=C1N GLNADSQYFUSGOU-GPTZEZBUSA-J 0.000 description 1
- 241000607598 Vibrio Species 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 210000001789 adipocyte Anatomy 0.000 description 1
- 238000005273 aeration Methods 0.000 description 1
- 229910000318 alkali metal phosphate Inorganic materials 0.000 description 1
- WNROFYMDJYEPJX-UHFFFAOYSA-K aluminium hydroxide Chemical compound [OH-].[OH-].[OH-].[Al+3] WNROFYMDJYEPJX-UHFFFAOYSA-K 0.000 description 1
- ILRRQNADMUWWFW-UHFFFAOYSA-K aluminium phosphate Chemical compound O1[Al]2OP1(=O)O2 ILRRQNADMUWWFW-UHFFFAOYSA-K 0.000 description 1
- 239000010775 animal oil Substances 0.000 description 1
- 230000000890 antigenic effect Effects 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 238000000376 autoradiography Methods 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 238000010804 cDNA synthesis Methods 0.000 description 1
- AIYUHDOJVYHVIT-UHFFFAOYSA-M caesium chloride Chemical compound [Cl-].[Cs+] AIYUHDOJVYHVIT-UHFFFAOYSA-M 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
- 239000005018 casein Substances 0.000 description 1
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 1
- 235000021240 caseins Nutrition 0.000 description 1
- 230000030833 cell death Effects 0.000 description 1
- 238000003570 cell viability assay Methods 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 235000013330 chicken meat Nutrition 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 239000012228 culture supernatant Substances 0.000 description 1
- 230000001086 cytosolic effect Effects 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 239000003599 detergent Substances 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 1
- 231100000676 disease causative agent Toxicity 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000001962 electrophoresis Methods 0.000 description 1
- 238000004520 electroporation Methods 0.000 description 1
- 238000005538 encapsulation Methods 0.000 description 1
- YQGOJNYOYNNSMM-UHFFFAOYSA-N eosin Chemical compound [Na+].OC(=O)C1=CC=CC=C1C1=C2C=C(Br)C(=O)C(Br)=C2OC2=C(Br)C(O)=C(Br)C=C21 YQGOJNYOYNNSMM-UHFFFAOYSA-N 0.000 description 1
- 238000012869 ethanol precipitation Methods 0.000 description 1
- 230000007717 exclusion Effects 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- GNBHRKFJIUUOQI-UHFFFAOYSA-N fluorescein Chemical compound O1C(=O)C2=CC=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 GNBHRKFJIUUOQI-UHFFFAOYSA-N 0.000 description 1
- 238000000799 fluorescence microscopy Methods 0.000 description 1
- 238000005194 fractionation Methods 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 231100000001 growth retardation Toxicity 0.000 description 1
- 150000008282 halocarbons Chemical class 0.000 description 1
- 230000002008 hemorrhagic effect Effects 0.000 description 1
- 230000003053 immunization Effects 0.000 description 1
- 238000002649 immunization Methods 0.000 description 1
- 238000010185 immunofluorescence analysis Methods 0.000 description 1
- 230000002163 immunogen Effects 0.000 description 1
- 230000001506 immunosuppresive effect Effects 0.000 description 1
- 229940031551 inactivated vaccine Drugs 0.000 description 1
- 230000000415 inactivating effect Effects 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 230000003834 intracellular effect Effects 0.000 description 1
- 238000007918 intramuscular administration Methods 0.000 description 1
- 239000007927 intramuscular injection Substances 0.000 description 1
- 238000001990 intravenous administration Methods 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 239000006194 liquid suspension Substances 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- NIQQIJXGUZVEBB-UHFFFAOYSA-N methanol;propan-2-one Chemical compound OC.CC(C)=O NIQQIJXGUZVEBB-UHFFFAOYSA-N 0.000 description 1
- WSFSSNUMVMOOMR-NJFSPNSNSA-N methanone Chemical compound O=[14CH2] WSFSSNUMVMOOMR-NJFSPNSNSA-N 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 210000003097 mucus Anatomy 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 230000002611 ovarian Effects 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- 238000007911 parenteral administration Methods 0.000 description 1
- 230000008807 pathological lesion Effects 0.000 description 1
- 230000007170 pathology Effects 0.000 description 1
- 235000020030 perry Nutrition 0.000 description 1
- 230000002688 persistence Effects 0.000 description 1
- 238000000053 physical method Methods 0.000 description 1
- 239000010773 plant oil Substances 0.000 description 1
- 229940012957 plasmin Drugs 0.000 description 1
- 229920002401 polyacrylamide Polymers 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 238000001243 protein synthesis Methods 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 238000012552 review Methods 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 238000005070 sampling Methods 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 235000010356 sorbitol Nutrition 0.000 description 1
- 238000005507 spraying Methods 0.000 description 1
- 238000010561 standard procedure Methods 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- 239000007929 subcutaneous injection Substances 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 230000009182 swimming Effects 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 125000003831 tetrazolyl group Chemical group 0.000 description 1
- 238000004448 titration Methods 0.000 description 1
- 241000701447 unidentified baculovirus Species 0.000 description 1
- 241001529453 unidentified herpesvirus Species 0.000 description 1
- 238000011144 upstream manufacturing Methods 0.000 description 1
- 230000001018 virulence Effects 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 238000001262 western blot Methods 0.000 description 1
- 239000002023 wood Substances 0.000 description 1
- 230000003462 zymogenic effect Effects 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2720/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
- C12N2720/00011—Details
- C12N2720/10011—Birnaviridae
- C12N2720/10022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2720/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
- C12N2720/00011—Details
- C12N2720/10011—Birnaviridae
- C12N2720/10041—Use of virus, viral particle or viral elements as a vector
- C12N2720/10043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2720/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
- C12N2720/00011—Details
- C12N2720/10011—Birnaviridae
- C12N2720/10061—Methods of inactivation or attenuation
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Biomedical Technology (AREA)
- General Health & Medical Sciences (AREA)
- Virology (AREA)
- General Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Biophysics (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Plant Pathology (AREA)
- Immunology (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US8017898P | 1998-03-31 | 1998-03-31 | |
| PCT/US1999/004285 WO1999050419A2 (fr) | 1998-03-31 | 1999-03-31 | Procede de generation de virus de necrose pancreatique infectieux, non pathogene, vivant (ipnv) a partir de produits de transcription d'arn synthetique |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| NO20004914D0 NO20004914D0 (no) | 2000-09-29 |
| NO20004914L NO20004914L (no) | 2000-11-23 |
| NO329660B1 true NO329660B1 (no) | 2010-11-22 |
Family
ID=22155757
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20004914A NO329660B1 (no) | 1998-03-31 | 2000-09-29 | cDNA, RNA, vektor, vertcelle, kimaert ikke-patogent akvatisk birnavirus, levende ikke-patogene IPNV, vaksine samt fremgangsmate for fremstilling |
| NO20082682A NO20082682L (no) | 1998-03-31 | 2008-06-16 | En fremgangsmate for a fremstille ikke-patogene, infeksiose pancreatiske nekrosevirus (IPNC) fra syntetisk RNA-transkripter |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20082682A NO20082682L (no) | 1998-03-31 | 2008-06-16 | En fremgangsmate for a fremstille ikke-patogene, infeksiose pancreatiske nekrosevirus (IPNC) fra syntetisk RNA-transkripter |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US6274147B1 (fr) |
| AU (1) | AU3353599A (fr) |
| CA (1) | CA2324478C (fr) |
| DK (1) | DK200001374A (fr) |
| NO (2) | NO329660B1 (fr) |
| WO (1) | WO1999050419A2 (fr) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6596280B1 (en) * | 1997-07-31 | 2003-07-22 | University Of Maryland Biotechnology Institute | Method for generating birnavirus from synthetic RNA transcripts |
| US20040001863A1 (en) * | 1998-12-03 | 2004-01-01 | Shau-Chi Chi | Immortal cell line derived from grouper Epinephelus coioides and its applications therein |
| US6630456B2 (en) * | 1999-11-23 | 2003-10-07 | Academia Sinica | Regulation of apoptosis in aquatic organisms by aquabirnavirus |
| CA2457349A1 (fr) * | 2001-08-10 | 2003-02-20 | University Of Maryland Biotechnology Institute | Vaccin sous-unite pour le virus de necrose pancreatique infectieux |
| WO2004003143A2 (fr) * | 2002-06-26 | 2004-01-08 | Advanced Bionutrition Corporation | Virus et particules pseudovirales pour presentation multiple d'antigenes et de cibles |
| TWI347364B (en) | 2003-02-19 | 2011-08-21 | Novartis Ag | Inactivated nodavirus vaccine |
| ES2217967B1 (es) * | 2003-03-31 | 2006-01-01 | Consejo Sup. Investig. Cientificas | Procedimiento de produccion de particulas virales vacias (vlps) del virus inductor de la bursitis infecciosa (ibdv), composiciones necesarias para su puesta a punto y su uso en la elaboracion de vacunas frente al ibdv. |
| ES2307345B1 (es) * | 2004-01-21 | 2009-11-13 | Consejo Sup. Investig. Cientificas | Capsidas vacias quimericas del virus causante de la enfermedad de la bursitis infecciosa (ibdv), su procedimiento de obtencion y aplicaciones. |
| ES2307346B1 (es) * | 2004-01-21 | 2009-11-13 | Consejo Sup. Investig. Cientificas | Capsidas vacias (vlps(-vp4)) del virus causante de la enfermedad de la bursitis infecciosa (ibdv), su procedimiento de obtencion y aplicaciones. |
| EP1773858B1 (fr) | 2004-05-27 | 2016-06-22 | Janssen Biotech, Inc. | Antigene specifique de la prostate du singe cynomolgus |
| AU2005329405A1 (en) * | 2004-06-15 | 2006-09-28 | Centocor, Inc. | Method for screening agents against human prostate disease |
| US7244432B2 (en) * | 2004-12-08 | 2007-07-17 | University Of Maryland Biotechnology Institute | Infectious bursal disease virus (IBDV) variant from Georgia |
| DE102005010288A1 (de) * | 2005-03-02 | 2006-09-07 | Riemser Arzneimittel Ag | Pharmazeutisches, oral applizierbares Präparat zur Behandlung von Fischen, Herstellungsverfahren für dieses und seine Verwendung |
| ES2310062B1 (es) * | 2005-07-15 | 2009-11-13 | Bionostra, S.L. | Particulas pseudovirales vacias quimericas derivadas del virus causante de la enfermedad de la bursitis infecciosa (ibdv), procedimiento de obtencion y aplicaciones. |
| WO2011012999A1 (fr) | 2009-07-31 | 2011-02-03 | Novartis Ag | Systemes de genetique inverse |
| NO332608B1 (no) * | 2011-03-16 | 2012-11-19 | Norwegian School Of Veterinary Science | Levende avirulent IPNV og vaksine for profylakse eller behandling av IPN-sykdom hos fisk |
| CN103937912B (zh) * | 2014-05-13 | 2016-07-20 | 吴斌 | 用于检测传染性胰脏坏死病毒的lamp引物组合物及其应用 |
| JP2022543423A (ja) | 2019-08-09 | 2022-10-12 | ナットクラッカー セラピューティクス， インコーポレイテッド | 治療用組成物から材料を除去するための製造方法および装置 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5788970A (en) | 1994-03-29 | 1998-08-04 | The University Of Maryland College Park | Chimeric infectious bursal disease virus CDNA clones, expression products and vaccines based thereon |
| US5871744A (en) * | 1996-09-05 | 1999-02-16 | University Of Maryland-Biotechnology Inst. | Method for generating birnavirus from synthetic RNA transcripts |
| EP0887412B1 (fr) * | 1997-05-26 | 2003-10-15 | Akzo Nobel N.V. | Vaccin recombinant du birnavirus |
| US6231868B1 (en) * | 1997-09-30 | 2001-05-15 | University Of Maryland-Biotechnology Institute | Method for generating nonpathogenic infections birnavirus from synthetic RNA transcripts |
-
1999
- 1999-03-31 AU AU33535/99A patent/AU3353599A/en not_active Abandoned
- 1999-03-31 CA CA2324478A patent/CA2324478C/fr not_active Expired - Fee Related
- 1999-03-31 US US09/282,147 patent/US6274147B1/en not_active Expired - Fee Related
- 1999-03-31 WO PCT/US1999/004285 patent/WO1999050419A2/fr active Application Filing
-
2000
- 2000-09-15 DK DK200001374A patent/DK200001374A/da not_active Application Discontinuation
- 2000-09-29 NO NO20004914A patent/NO329660B1/no not_active IP Right Cessation
-
2008
- 2008-06-16 NO NO20082682A patent/NO20082682L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| NO20004914D0 (no) | 2000-09-29 |
| US6274147B1 (en) | 2001-08-14 |
| NO20082682L (no) | 2000-11-23 |
| WO1999050419A3 (fr) | 1999-11-18 |
| CA2324478A1 (fr) | 1999-10-07 |
| DK200001374A (da) | 2000-11-23 |
| NO20004914L (no) | 2000-11-23 |
| CA2324478C (fr) | 2011-08-23 |
| WO1999050419A2 (fr) | 1999-10-07 |
| AU3353599A (en) | 1999-10-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO329660B1 (no) | cDNA, RNA, vektor, vertcelle, kimaert ikke-patogent akvatisk birnavirus, levende ikke-patogene IPNV, vaksine samt fremgangsmate for fremstilling | |
| McLoughlin et al. | Alphavirus infections in salmonids–a review | |
| CA2298956C (fr) | Culture de cellules genetiquement modifiees adaptee aux mutants du virus de la bursite infectieuse (ibvd) | |
| Shivappa et al. | Molecular characterization of Sp serotype strains of infectious pancreatic necrosis virus exhibiting differences in virulence | |
| Allnutt et al. | Antigenicity of infectious pancreatic necrosis virus VP2 subviral particles expressed in yeast | |
| Jackwood | Multivalent virus-like–particle vaccine protects against classic and variant infectious bursal disease viruses | |
| Lopez-Doriga et al. | Isolation of salmon pancreas disease virus (SPDV) in cell culture and its ability to protect against infection by the ‘wild-type’agent | |
| CN104561049A (zh) | 一种表达猪细小病毒vp2蛋白的重组杆状病毒及制备方法与应用 | |
| CN100506989C (zh) | 镶嵌传染性腔上囊病病毒疫苗 | |
| Guo et al. | Recombinant infectious hematopoietic necrosis virus expressing infectious pancreatic necrosis virus VP2 protein induces immunity against both pathogens | |
| US6231868B1 (en) | Method for generating nonpathogenic infections birnavirus from synthetic RNA transcripts | |
| NO332608B1 (no) | Levende avirulent IPNV og vaksine for profylakse eller behandling av IPN-sykdom hos fisk | |
| Foster | Viruses as pathogens: animal viruses affecting wild and domesticated species | |
| US7022327B1 (en) | Recombinant birnavirus vaccine | |
| EP0887412B1 (fr) | Vaccin recombinant du birnavirus | |
| Stoute et al. | Viral infections of waterfowl | |
| Mundt et al. | Development of a vaccine for immunization against classical as well as variant strains of infectious bursal disease virus using reverse genetics | |
| Rimstad | Vaccination against infectious pancreatic necrosis | |
| CA2591532A1 (fr) | Sequences d'acides nucleiques codant pour des proteines capables de s'associer a une pseudo-particule virale | |
| Patel et al. | Immunoprophylaxis against important virus diseases of horses, farm animals and birds | |
| US9345760B2 (en) | IPNV-ISAV bivalent vaccine using a virus-like particle-based platform and methods of using the same | |
| KR102421249B1 (ko) | 국내 분리 미주형 항원변이형 닭전염성 f낭병 바이러스 및 이를 포함하는 백신조성물 | |
| KR102421251B1 (ko) | 국내 분리 중국형 항원변이형 닭전염성 f낭병 바이러스 및 이를 포함하는 백신조성물 | |
| Harris | Characterization of infectious bursal disease viruses isolated from commercial chickens | |
| Shivappa | Identification of molecular markers for virulence in infectious pancreatic necrosis virus and development of a subunit vaccine |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MM1K | Lapsed by not paying the annual fees |